Tuğba Akın Telli

643 total citations
47 papers, 389 citations indexed

About

Tuğba Akın Telli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tuğba Akın Telli has authored 47 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Tuğba Akın Telli's work include Radiomics and Machine Learning in Medical Imaging (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Tuğba Akın Telli is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (7 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Tuğba Akın Telli collaborates with scholars based in Türkiye, Belgium and Italy. Tuğba Akın Telli's co-authors include Giacomo Bregni, Francesco Sclafani, Alain Hendlisz, Perran Fulden Yumuk, Silvia Camera, Özlem Erçelep, Amélie Deleporte, Özkan Alan, Faysal Dane and Nalan Akgül Babacan and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Letters and Breast Cancer Research and Treatment.

In The Last Decade

Tuğba Akın Telli

43 papers receiving 386 citations

Peers

Countries citing papers authored by Tuğba Akın Telli

Since Specialization

Citations

This map shows the geographic impact of Tuğba Akın Telli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuğba Akın Telli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuğba Akın Telli more than expected).

Fields of papers citing papers by Tuğba Akın Telli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuğba Akın Telli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuğba Akın Telli. The network helps show where Tuğba Akın Telli may publish in the future.

Co-authorship network of co-authors of Tuğba Akın Telli

This figure shows the co-authorship network connecting the top 25 collaborators of Tuğba Akın Telli. A scholar is included among the top collaborators of Tuğba Akın Telli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuğba Akın Telli. Tuğba Akın Telli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients 2024 ·International Journal of Breast Cancer ·(unknown), (unknown), (unknown), (unknown), Mustafa Ümit Uğurlu, Özkan Alan, Tuğba Akın Telli, Perran Fulden Yumuk, Mustafa Akkіprіk	1
2	Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens 2023 ·Oncology Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), Tuğba Akın Telli, (unknown), (unknown), (unknown), Çiğdem Çelikel, (unknown), İbrahim Vedat Bayoğlu, Osman Köstek, Faysal Dane, Perran Fulden Yumuk	2
3	Prediction of nipple involvement in breast cancer after neoadjuvant chemotherapy: Should we rely on breast MRI to preserve the nipple? 2023 ·Breast Cancer Research and Treatment ·Mustafa Ümit Uğurlu, (unknown), (unknown), Handan Kaya, Tuğba Akın Telli, Haldun Akoğlu, Bahadır M. Güllüoğlu	0
4	Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma 2022 ·Nutrition and Cancer ·Tuğba Akın Telli, (unknown), Özkan Alan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bülent Erol, (unknown), Osman Köstek, İbrahim Vedat Bayoğlu, Özlem Erçelep, (unknown), Perran Fulden Yumuk	1
5	Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy 2022 ·Future Oncology ·Tuğba Akın Telli, Mehmet Akif Öztürk, Özkan Alan, (unknown), Osman Köstek, (unknown), (unknown), Serap Kaya, Özlem Erçelep, Nalan Akgül Babacan, Faysal Dane, Perran Fulden Yumuk	0
6	Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters 2022 ·Acta Radiologica ·(unknown), (unknown), Tuğba Akın Telli, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), İlker Tınay, Trevor Jones, Halil Turgut Turoğlu, Tanju Yusuf Erdıl, Mehmet Akif Öztürk, Özlem Erçelep, İbrahim Vedat Bayoğlu, Osman Köstek, Faysal Dane, Perran Fulden Yumuk	2
7	Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study 2022 ·Oncology Research and Treatment ·(unknown), Baran Akagündüz, (unknown), (unknown), Tuğba Akın Telli, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abdullah Sakin	3
8	Predictive value of 18F-FDG PET/CT indices on extensive residual cancer burden in breast cancer patients treated with neoadjuvant chemotherapy 2021 ·Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) ·(unknown), (unknown), (unknown), (unknown), Osman Köstek, (unknown), (unknown), Tuğba Akın Telli, Özlem Erçelep, Handan Kaya, (unknown), Tanju Yusuf Erdıl, Mustafa Ümit Uğurlu, Faysal Dane, Perran Fulden Yumuk	2
9	QT interval prolongation related to afatinib treatment in a patient with metastatic non–small-cell lung cancer 2020 ·Current Problems in Cancer ·(unknown), Tuğba Akın Telli, (unknown), (unknown), (unknown), (unknown), Özlem Erçelep, Faysal Dane, Perran Fulden Yumuk	4
10	A rare case of gastric cancer with bilateral breast metastasis during pregnancy 2020 ·Journal of Oncology Pharmacy Practice ·(unknown), Tuğba Akın Telli, (unknown), (unknown), Özlem Erçelep, (unknown), (unknown), Aslı Memişoğlu, Faysal Dane, Perran Fulden Yumuk	5
11	VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature 2020 ·Current Problems in Cancer ·Tuğba Akın Telli, İlker Ökten, (unknown), (unknown), (unknown), Özkan Alan, Özlem Erçelep, Trevor Jones, (unknown), Faysal Dane, Perran Fulden Yumuk	11
12	Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment 2020 ·Clinical Neurology and Neurosurgery ·Özkan Alan, Tuğba Akın Telli, (unknown), (unknown), (unknown), Özlem Erçelep, Süheyla Bozkurt, Beste M. Atasoy, Faysal Dane, Perran Fulden Yumuk	4
13	Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma 2020 ·Tumori Journal ·Özlem Erçelep, Özkan Alan, Tuğba Akın Telli, (unknown), (unknown), (unknown), (unknown), Nalan Akgül Babacan, Serap Kaya, Faysal Dane, Emine Bozkurtlar, Trevor Jones, Tunç Laçin, Perran Fulden Yumuk	5
14	Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature 2020 ·Current Problems in Cancer ·(unknown), Tuğba Akın Telli, (unknown), (unknown), Özlem Erçelep, Beste M. Atasoy, (unknown), Faysal Dane, Perran Fulden Yumuk	7
15	Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience 2020 ·Journal of Oncology Pharmacy Practice ·Özkan Alan, Tuğba Akın Telli, (unknown), (unknown), (unknown), Özlem Erçelep, Serap Kaya, Nalan Akgül Babacan, Beste M. Atasoy, Süheyla Bozkurt, Yaşar Bayri, (unknown), Gazanfer Ekinci, Ibrahim M. Ziyal, Faysal Dane, Perran Fulden Yumuk	2
16	Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy 2020 ·Clinical Breast Cancer ·Mustafa Akkіprіk, (unknown), Mustafa Ümit Uğurlu, (unknown), (unknown), Özkan Alan, Can Erzık, (unknown), Tuğba Akın Telli, (unknown), Osman Uğur Sezerman, Perran Fulden Yumuk	7
17	Comparison of two different carboplatin and weekly paclitaxel schedule in elderly advanced non-small cell lung cancer patients 2019 ·Cancer Chemotherapy and Pharmacology ·(unknown), Tuğba Akın Telli, Ali Murat Tatlı, (unknown), Perran Fulden Yumuk	1
18	Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice 2019 ·Cancer Treatment Reviews ·Giacomo Bregni, Tuğba Akın Telli, Silvia Camera, Amélie Deleporte, L. Moretti, A Bali, Gabriel Liberale, Stéphane Holbrechts, Alain Hendlisz, Francesco Sclafani	56
19	A case of primary squamous cell carcinoma of the breast with pathologic complete response after neoadjuvant chemotherapy 2018 ·Current Problems in Cancer ·Özkan Alan, Tuğba Akın Telli, Özlem Erçelep, (unknown), (unknown), (unknown), Trevor Jones, Handan Kaya, Perran Fulden Yumuk	9
20	The effect of thyroid autoantibody positivity on the functions of internal ear 2017 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), Tuğba Akın Telli, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact